With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Find out which weight loss injections work best, how fast you can expect results, and whether combining them with other ...

Liraglutide is on the market as Victoza for diabetes and Saxenda for obesity ... and Wegovy for obesity – which can be dosed by injection once a week. Novo Nordisk is already running the ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

But, the local drug dealers claim to import and sell the injection for Rs 20,000 per shot ... offer a generic version of Novo ...

Already on the market for obesity is Saxenda (Victoza under a different ... a combination of Tresiba and Victoza in one injection, but this faces direct competition from Sanofi’s similar product ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

The warning applies to GLP-1 receptor agonists including Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro and Zepbound. The medical news website Medscape first reported the warning label ...